August 30, 2024
Boehringer Ingelheim announces appointments Board of Managing Directors
August 27, 2024
Boehringer Ingelheim to unveil groundbreaking oncology research at WCLC
July 29, 2024
Boehringer Ingelheim acquires Nerio Therapeutics
July 29, 2024
CHMP adopts positive opinion recommending approval of new and expanded indications for SPEVIGO®
July 18, 2024
First half of 2024: Boehringer Ingelheim progresses pipeline at pace and reaches major milestones
July 08, 2024
Boehringer Ingelheim produces its own green energy
July 03, 2024
Boehringer Ingelheim advances SIRPα immuno-oncology program
July 01, 2024
Phase 1 start for novel triple agonist obesity treatment
June 07, 2024
Survodutide shows breakthrough improvement in liver fibrosis
May 28, 2024
Outdated perceptions and practices fuelling mental health crisis, new Economist Impact study reveals
May 22, 2024
Partnership for first-in-class cancer and CRM treatments
May 13, 2024